Chimeric Antigen Receptor – T cell (CAR-T) therapy is one of the most exciting, promising treatment breakthroughs in recent years. Texas Oncology is one of the very few authorized centers in the country to initially provide CAR-T therapy. Learn more about how CAR-T therapy works in this video:
A type of immunotherapy, CAR-T therapy galvanizes the body’s immune system to fight cancer. It uses genetically engineered immune T cells to recognize specific proteins on tumor cells. Some of a patient’s white blood cells are extracted, modified, and replicated so that they recognize and attack cancer cells. View an infographic from The Leukemia & Lymphoma Society that explains CAR-T therapy here.
Click the graphic to see a larger version
Car T-cell Therapy
Eligible Patients
CAR-T provides another treatment option when standard treatments are not effective. Adult patients who have been diagnosed with either relapsed or refractory large B-cell lymphoma, a type of non-Hodgkin lymphoma, or acute lymphocytic leukemia, and who have failed two or more types of therapy may be eligible. CAR-T clinical trials may be available for other hematologic malignancies or solid tumors, including non-Hodgkin lymphoma, acute lymphocytic leukemia, multiple myeloma, chronic lymphocytic leukemia, pancreatic cancer, and others.
Texas Oncology offers CAR-T therapy at two Dallas area locations, through collaborations with Baylor University Medical Center and Medical City Dallas Hospital.
Request an Appointment or More Information
Patients interested in CAR-T therapy should contact:
Telemedicine
Patients who are eligible for CAR-T treatment and who live outside the Dallas area may be able to access CAR-T treatment experts via telemedicine, in conjunction with a local Texas Oncology physician in the patient’s community. In some cases, patients could receive initial consultations and assistance with managing aspects of follow-up care via telemedicine. While this may provide added convenience for out-of-town patients, patients will need to travel to Dallas for treatment. Learn more about telemedicine.
Latest News